Atlas Trials

Everolimus in Treating Patients With Progressive or Recurrent, Unresectable, or Metastatic Thyroid Cancer

Clinical trial NCT01118065 · UNKNOWN

Trial details

NCT number
NCT01118065
Sponsor
Leiden University Medical Center
Status
UNKNOWN
Phase
Phase 2
Study type
INTERVENTIONAL
Head and Neck Cancer
Start date
2010-05-01
Primary completion
2012-05-01
Enrollment
42

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.